LinkedIn Profile

Access Springleaf Therapeutics historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal GICS Sector GICS Industry
private:springleaftherapeutics 2426585 Jul 2nd, 2020 12:00AM SpringLeaf Therapeutics 45 1.00 Open Biotechnology Jul 2nd, 2020 07:53PM Jul 2nd, 2020 07:53PM SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com. Open Financial Services
private:springleaftherapeutics 2426585 Jul 1st, 2020 12:00AM SpringLeaf Therapeutics 45 1.00 Open Biotechnology Jun 30th, 2020 08:09PM Jul 1st, 2020 06:31PM SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com. Open Financial Services
private:springleaftherapeutics 2426585 Jun 29th, 2020 12:00AM SpringLeaf Therapeutics 45 1.00 Open Biotechnology Jun 29th, 2020 02:33PM Jun 29th, 2020 02:33PM SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com. Open Financial Services
private:springleaftherapeutics 2426585 Jun 28th, 2020 12:00AM SpringLeaf Therapeutics 45 1.00 Open Biotechnology Jun 28th, 2020 07:57PM Jun 28th, 2020 07:57PM SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com. Open Financial Services
private:springleaftherapeutics 2426585 Jun 27th, 2020 12:00AM SpringLeaf Therapeutics 45 1.00 Open Biotechnology Jun 27th, 2020 05:21PM Jun 27th, 2020 05:21PM SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com. Open Financial Services
private:springleaftherapeutics 2426585 Jun 26th, 2020 12:00AM SpringLeaf Therapeutics 45 1.00 Open Biotechnology Jun 26th, 2020 05:55PM Jun 26th, 2020 05:55PM SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com. Open Financial Services
private:springleaftherapeutics 2426585 Jun 25th, 2020 12:00AM SpringLeaf Therapeutics 45 1.00 Open Biotechnology Jun 25th, 2020 06:52PM Jun 25th, 2020 06:52PM SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com. Open Financial Services
private:springleaftherapeutics 2426585 Jun 24th, 2020 12:00AM SpringLeaf Therapeutics 45 1.00 Open Biotechnology Jun 24th, 2020 02:41PM Jun 24th, 2020 02:41PM SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com. Open Financial Services
private:springleaftherapeutics 2426585 Jun 23rd, 2020 12:00AM SpringLeaf Therapeutics 45 1.00 Open Biotechnology Jun 23rd, 2020 05:17PM Jun 23rd, 2020 06:59PM SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com. Open Financial Services
private:springleaftherapeutics 2426585 Jun 22nd, 2020 12:00AM SpringLeaf Therapeutics 49 1.00 Open Biotechnology Jun 22nd, 2020 07:54PM Jun 22nd, 2020 07:54PM SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com. Open Financial Services

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.